Literature DB >> 9157954

In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima.

L B Nielsen1, M L Grønholdt, T V Schroeder, S Stender, B G Nordestgaard.   

Abstract

The aim of this study was to compare the atherogenic potential of lipoprotein(a) [Lp(a)] and LDL by measuring the intimal clearance of these two plasma lipoproteins in the atherosclerotic intima of the human carotid artery in vivo. Autologous 131I-Lp(a) and 125I-LDL were mixed and reinjected intravenously 3 hours before elective surgical removal of the arterial intima in four patients. The intimal clearance of Lp(a) and LDL was 229+/-48 and 405+/-127 nL/cm2 per hour, respectively (paired t test; P=.12). The mass accumulation of Lp(a) (114+/-32 ng/cm2 per hour) was on average one 15th that of LDL (paired t test; P=.06), mainly reflecting a low plasma concentration of Lp(a) compared with LDL in the human subjects studied. In accordance with our previous observation in rabbits, there was a positive association between the intimal clearance of LDL and that of Lp(a) (r=.97, P=.03). Accordingly, high plasma levels of Lp(a) may share with LDL the potential for causing lipid accumulation in the arterial intima in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157954     DOI: 10.1161/01.atv.17.5.905

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

Review 1.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

2.  HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?

Authors:  Claudia Stefanutti; Claudia Morozzi
Journal:  Blood Transfus       Date:  2016-06-29       Impact factor: 3.443

Review 3.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

Review 4.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 5.  Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.

Authors:  Sotirios Tsimikas
Journal:  Circ Res       Date:  2019-02       Impact factor: 17.367

Review 6.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

7.  Coronary Artery Disease Severity and Cardiovascular Biomarkers in Patients with Peripheral Artery Disease.

Authors:  Hiroyuki Hikita; Takatoshi Shigeta; Shigeki Kimura; Atsushi Takahashi; Mitsuaki Isobe
Journal:  Int J Angiol       Date:  2015-06-26

Review 8.  Genetic risk factors for spontaneous intracerebral haemorrhage.

Authors:  Amanda M Carpenter; Inder P Singh; Chirag D Gandhi; Charles J Prestigiacomo
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

Review 9.  Advances in lipid-lowering therapy through gene-silencing technologies.

Authors:  Børge G Nordestgaard; Stephen J Nicholls; Anne Langsted; Kausik K Ray; Anne Tybjærg-Hansen
Journal:  Nat Rev Cardiol       Date:  2018-02-08       Impact factor: 32.419

10.  Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels.

Authors:  Kazuhiko Kotani; Naoki Sakane
Journal:  J Clin Med Res       Date:  2012-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.